| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 01/23/2013 | CN102892758A Pyridine and pyrazine derivative for the treatment of cf |
| 01/23/2013 | CN102892754A Arylsulfonamide ccr3 antagonists |
| 01/23/2013 | CN102892290A Noxious organism control agent |
| 01/23/2013 | CN102887891A N4-phenyl-quinaz0line-4 -amine derivatives and related compounds |
| 01/23/2013 | CN102887889A Heterocyclic substitute dpyrimidines |
| 01/23/2013 | CN102887888A Yellowing inhibitor based on naphthalimide fluorescent whitening agent, and preparation method and application thereof |
| 01/23/2013 | CN102887887A 2-(1-substituted piperidine-4-amino)-6-(substituted phenylamine/phenol) pyridine derivatives and preparation method and application thereof |
| 01/23/2013 | CN102887886A Preparation method of pantoprazole sodium |
| 01/23/2013 | CN102887885A Preparation method of esomeprazole sodium |
| 01/23/2013 | CN102887867A Triazine compound and preparation method and application of triazine compound |
| 01/23/2013 | CN102351847B Industrial method for refining esomeprazole sodium salt |
| 01/23/2013 | CN102321071B Industrial production method of high-purity esomeprazole sodium |
| 01/23/2013 | CN102093337B Preparation method of acetyl benzimidazole pyridine salt |
| 01/23/2013 | CN101910127B (aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor |
| 01/23/2013 | CN101671328B Novel synthesis method of sulfonylurea weedicide |
| 01/23/2013 | CN101490017B Therapeutic piperazines as pde4 inhibitors |
| 01/23/2013 | CN101481513B Preparation of reactive dye for cotton |
| 01/23/2013 | CN101128456B Quinazoline derivatives as tyrosine kinase inhibitors |
| 01/22/2013 | US8357805 (1R,1′R)-atracurium salts separation process |
| 01/22/2013 | US8357686 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |
| 01/22/2013 | US8357674 Analogues of cilostazol |
| 01/22/2013 | CA2756104C Pyridine thio derivative, and pharmaceutical composition which contains same and has anti-helicobacter pylori action |
| 01/22/2013 | CA2650932C Substituted spirocyclic cgrp receptor antagonists |
| 01/22/2013 | CA2537812C C-met modulators and method of use |
| 01/22/2013 | CA2515777C Biphenyl derivatives |
| 01/17/2013 | WO2013009543A1 Polycyclic pyrrolidine-2,5-dione derivatives as -formyl peptide receptor like-1 (fprl-1) receptor modulators |
| 01/17/2013 | WO2013008217A1 4 - piperidinyl compounds for use as tankyrase inhibitors |
| 01/17/2013 | WO2013007959A1 Novel imaging agents, process for the preparation thereof and pharmaceutical compositions containing same |
| 01/17/2013 | WO2013007676A1 Aminomethyl quinolone compounds |
| 01/17/2013 | WO2013007604A1 Method for producing tetrazole-substituted anthranilic acid diamide derivatives by reacting pyrazolic acids with anthranilic acid esters |
| 01/17/2013 | WO2013007519A1 Polymorphs of 6-(piperidin-4-yloxy)-2h-isoquinolin-1-one hydrochloride |
| 01/17/2013 | WO2013007518A1 Crystalline solvates of 6-(piperidin-4-yloxy)-2h-isoquinolin-1-one hydrochloride |
| 01/17/2013 | WO2013007184A1 Antineoplastic drug tetrahydronaphthalene amide-group compound and pharmaceutically acceptable salt, preparation method and use thereof |
| 01/17/2013 | WO2013007168A1 Preparation and use of pyrrole and dihydropyrrole fused ring compound having insecticidal activity |
| 01/17/2013 | WO2013007106A1 Spiro compounds as hepatitis c virus inhibitors |
| 01/17/2013 | WO2012146724A3 Novel rock inhibitors |
| 01/17/2013 | WO2012129452A3 Propynoic acid carbamoyl methyl-amides and pharmaceutical compositions and methods based thereon |
| 01/17/2013 | US20130018192 Aryl-substituted Pyrazoles |
| 01/17/2013 | US20130018189 2-phenyl-6-azolylpyridine-based ligand and group viii transition metal complex |
| 01/17/2013 | US20130018188 Preparation of anhydrous and hydrated polymorphs of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one-lactic acid salt |
| 01/17/2013 | US20130018140 N-bridged polynitrons and the use thereof as cross-linking agents, in particular in coating materials and adhesives |
| 01/17/2013 | US20130018075 Heterocyclic inhibitors of mek and methods of use thereof |
| 01/17/2013 | US20130018073 Indole derivative |
| 01/17/2013 | US20130018067 Polycyclic pyrrolidine-2,5-dione derivatives as -formyl peptide receptor like-1 (fprl-1) receptor modulators |
| 01/17/2013 | US20130018064 Amino Heteroaryl Compounds as Beta-Secretase Modulators and Methods of Use |
| 01/17/2013 | US20130018058 Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties |
| 01/17/2013 | US20130018054 New compounds |
| 01/17/2013 | US20130018051 Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 01/17/2013 | US20130018046 Acetylenic Heteroaryl Compounds |
| 01/17/2013 | US20130018043 Aminomethyl quinolone compounds |
| 01/17/2013 | US20130018039 Imidazolyl-imidazoles as kinase inhibitors |
| 01/17/2013 | US20130018033 Raf inhibitor compounds and methods of use thereof |
| 01/17/2013 | US20130018031 Aminoalkylpyrimidine derivatives as histamine h4 receptor antagonists |
| 01/17/2013 | US20130017196 Substituted imidazole derivatives |
| 01/17/2013 | US20130017194 Fak inhibitors |
| 01/17/2013 | US20130017149 Pharmaceutical compounds |
| 01/17/2013 | CA2843777A1 Polymorphs of 6-(piperidin-4-yloxy)-2h-isoquinolin-1-one hydrochloride |
| 01/17/2013 | CA2843773A1 Crystalline solvates of 6-(piperidin-4-yloxy)-2h-isoquinolin-1-one hydrochloride |
| 01/17/2013 | CA2841983A1 Polycyclic pyrrolidine-2,5-dione derivatives as -formyl peptide receptor like-1 (fprl-1) receptor modulators |
| 01/17/2013 | CA2841932A1 4 - piperidinyl compounds for use as tankyrase inhibitors |
| 01/17/2013 | CA2841095A1 Spiro compounds as hepatitis c virus inhibitors |
| 01/17/2013 | CA2839395A1 Aminomethyl quinolone compounds |
| 01/16/2013 | EP2546253A1 Substituted dihydropyrazolones for the treatment of cardiovascular and hematological diseases |
| 01/16/2013 | EP2546252A1 Heteroaryl-substituted 1,3 dihydroindol-2-one derivatives and medicaments containing them |
| 01/16/2013 | EP2546251A1 Heteroaryl-substituted 1,3 dihydroindol-2-one derivatives and medicaments containing them |
| 01/16/2013 | EP2546250A1 Heteroaryl-substituted 1,3 dihydroindol-2-one derivatives and medicaments containing them |
| 01/16/2013 | EP2546249A1 5-Alkynyl-pyridines |
| 01/16/2013 | EP2546248A1 Crystal form H of imatinib mesylate |
| 01/16/2013 | EP2546247A1 Imatinib mesylate preparation procedure |
| 01/16/2013 | EP2546236A1 Compound containing pyridine ring and method for producing halogenated picoline derivative and tetrazolyloxime derivative |
| 01/16/2013 | EP2546235A1 PROCESS FOR PREPARATION OF t-BUTOXYCARBONYLAMINE COMPOUNDS |
| 01/16/2013 | EP2546232A1 Diphenyl Substituted Alkanes |
| 01/16/2013 | EP2545047A1 Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5) |
| 01/16/2013 | EP2545046A1 N-acyl cyclic amine derivative or pharmaceutically acceptable salt thereof |
| 01/16/2013 | EP2545045A1 Piperidin-4-yl azetidine derivatives as jak1 inhibitors |
| 01/16/2013 | EP2545044A1 Dabigatran etexilate-containing pharmaceutical composition |
| 01/16/2013 | EP2545043A1 Anhydrous lenalidomide form-i |
| 01/16/2013 | EP2545042A1 Compounds for the treatment of hepatitis c |
| 01/16/2013 | EP2545037A1 Inhibitors of protein kinases |
| 01/16/2013 | EP2545034A1 A process for amidation of pyrrole carboxylate compounds |
| 01/16/2013 | EP2544684A1 4,4-disubstituted piperidine derivatives useful as inhibitors of dipeptidyl peptidase-1 (dpp-1) |
| 01/16/2013 | EP2281822B1 New dihydroindolone derivatives, method of preparing same and pharmaceutical compositions containing them |
| 01/16/2013 | CN102884156A Light-emitting device material and light-emitting device |
| 01/16/2013 | CN102884060A Heterocyclic compounds useful for kinase inhibition |
| 01/16/2013 | CN102884059A N-酰基环胺衍生物或其可药用盐 N- acyl cyclic amine derivative or pharmaceutically acceptable salt thereof |
| 01/16/2013 | CN102884058A 1-cyclopropyl-8-methyl-7-[5-methyl-6-(methylamino)-3-pyridinyl]-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid salts |
| 01/16/2013 | CN102884057A 雄激素受体调节剂及其用途 Androgen receptor modulators and their use |
| 01/16/2013 | CN102884053A Cyclopropanecarboxylic acid derivative |
| 01/16/2013 | CN102884052A Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 01/16/2013 | CN102884049A Heterocyclic amides as ROCK inhibitors |
| 01/16/2013 | CN102884048A Amino-heteroaryl derivatives as HCN blockers |
| 01/16/2013 | CN102884047A 2-pyridone compounds |
| 01/16/2013 | CN102884044A Derivatives of aminoindanes, their preparation and their application in therapeutics |
| 01/16/2013 | CN102883606A Hydrazine-substituted anthranilic acid derivatives |
| 01/16/2013 | CN102875552A Composite solvent for efficiently extracting alkaloids |
| 01/16/2013 | CN102875533A Dabigatran derivative, preparation method of dabigatran derivative and anti-thrombus application |
| 01/16/2013 | CN102875532A (R)-lansoprazole isopropyl amine salt and crystal form and preparation method thereof |
| 01/16/2013 | CN102875531A (R)-lansoprazole unhydrous crystal and preparation method thereof |
| 01/16/2013 | CN102875530A (R)-lansoprazole tert-butylamine salt and crystal form and preparation method thereof |
| 01/16/2013 | CN102875529A Dabigatran derivatives and preparation method thereof |